HIV Policy and Advocacy
The Latest
Indigenous Communities in Mexico and Elsewhere Demand a Seat at the Table
"We have never been silent, but you have not heard us": Advocates demonstrate to demand inclusion of indigenous issues in the HIV response.
Marginalized Groups Are Focus of IAS 2019 Forum
Activists working on human rights discuss the challenges of achieving an end to the HIV epidemic.
IAS 2019: What to Expect in HIV Science
Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.
In Georgia's Metropolitan Heart, HIV Beats On
Our new "Eyes on the End" series kicks off with an up-close-and-personal glimpse at what's driving the HIV epidemic in the Atlanta metropolitan area.
HIV Advocacy Group Spars With Express Scripts Over HIV Drug Formulary Changes
Starting July 1, some HIV meds that are widely used will be excluded from their list.
Trump Administration Ends Fetal Tissue Research, Cancels Major HIV Grant
Advocates say the move is more politics than science.
Ending the HIV Epidemic Will Take More Than Medicine
Our HIV research agenda has to address the world outside of a clinical trial, vaccine researcher Stephaun E. Wallace, Ph.D., argues.
Plan to End HIV Epidemic in U.S. Must Contend With Uneven State Health Care Systems
Best practices need to be replicated, but our health care structure will make doing so more challenging, says Ace Robinson of the Fast-Track Cities initiative.
Primary Care Providers Aware of PrEP in NYC Suburbs, but Report Barriers to Prescribing
Anthony J. Santella, Dr.P.H., explains why prevention efforts are lagging within the largest suburban HIV epidemic in the U.S.
Long-Acting HIV Treatment Is Coming. Our Health Care System Needs to Prepare
Providers, payers, and health systems need to catch up, said Melanie Thompson, M.D., at the ACTHIV conference.